Melanoma, Cutaneous Malignant
Oncology·MeSH: Melanoma, Cutaneous Malignant
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Melanoma, Cutaneous Malignant?
BioSniper tracks 2 drugs in development for Melanoma, Cutaneous Malignant across 1 company.
How many clinical trials target Melanoma, Cutaneous Malignant?
There are 1 clinical trial targeting Melanoma, Cutaneous Malignant tracked by BioSniper.
What is the prevalence of Melanoma, Cutaneous Malignant?
The estimated prevalence of Melanoma, Cutaneous Malignant is approximately 75.0 per 100,000 population.
Deep-dive into Melanoma, Cutaneous Malignant
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis